financetom
Technology
financetom
/
Technology
/
Broadcom unveils new tech to speed up custom chips amid rising GenAI demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Broadcom unveils new tech to speed up custom chips amid rising GenAI demand
Dec 5, 2024 6:22 AM

(Reuters) - Broadcom ( AVGO ) said on Thursday its custom chip unit, which makes AI processors for cloud providers, has developed new technology to enhance semiconductor speeds amid escalating demand for generative artificial intelligence infrastructure.

Palo Alto, California-based Broadcom ( AVGO ) is among the biggest beneficiaries of hefty demand for AI-supporting hardware, as so-called hyperscalers turn to its custom chips to diversify their supply chains beyond Nvidia's ( NVDA ) costly processors.

The technology, called 3.5D XDSiP, will allow Broadcom's ( AVGO ) custom-chip customers to boost the amount of memory inside each packaged chip and speed up its performance by directly connecting critical components.

To do this, it uses manufacturing processes from TSMC, the world's largest contract-chip producer, including chip-on-wafer-on-substrate techniques - also known as advanced packaging - capacity for which is limited, making it a key bottleneck in the supply chain for AI chips.

There are five products in development that use the new tech, with production shipments starting in February 2026, Broadcom ( AVGO ) said.

While Broadcom ( AVGO ) does not identify the cloud companies it is developing custom chips for, analysts widely believe tech giant Alphabet's Google and Facebook-owner Meta Platforms are among its customers.

"Our hyperscale customers continue to scale up and scale out their AI clusters," Broadcom ( AVGO ) CEO Hock Tan said in September, when the company raised its forecast for AI revenue to $12 billion for fiscal year 2024, up from an earlier forecast of $11 billion.

The chipmaker, which also provides networking equipment for data centers, has three main customers for its custom processor unit, Tan said in September.

Broadcom's ( AVGO ) central competitor in this space is Marvell. The total market for custom chips could grow to about $45 billion by 2028 and be split between the two companies, Marvell COO Chris Koopmans said on Tuesday.

The market for custom chips will expand further, Summit Insights senior analyst Kinngai Chan said, adding that Marvell and Broadcom ( AVGO ) would benefit from this trend. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TransAlta to Host Annual and Special Meeting of Shareholders and First Quarter 2026 Results Conference Call
TransAlta to Host Annual and Special Meeting of Shareholders and First Quarter 2026 Results Conference Call
Apr 7, 2026
CALGARY, Alberta, April 07, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation ( TAC ) 2026 Annual and Special Meeting of TransAlta Corporation Shareholders On Thursday, April 30, 2026, TransAlta Corporation ( TAC ) will hold its annual and special meeting of shareholders at 11:30 a.m. Mountain Time (1:30 p.m. Eastern Time) in a virtual-only meeting format via live audio webcast (https://meetings.lumiconnect.com/400-012-606-918)....
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update
Apr 7, 2026
Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a potential best-in-class/first-in-class Claudin 18.2-directed bispecific antibody for gastric cancer, has shown robust and durable responses with broad CLDN18.2 activity, favorable safety, as well as potential eligibility for FDA’s Accelerated Approval Pathway with potential initiation of a registrational Phase 3 trial...
At ASCRS/ASOA 2026, the Saffron Solution Exposes the Hidden Operational Leaks Costing Ophthalmology Practices Growth, Access, and Revenue
At ASCRS/ASOA 2026, the Saffron Solution Exposes the Hidden Operational Leaks Costing Ophthalmology Practices Growth, Access, and Revenue
Apr 7, 2026
As ASCRS and ASOA 2026 begin, a new model for ophthalmology practices emerges—focused on eliminating operational gaps, improving patient access, and driving measurable growth WASHINGTON, April 7, 2026 /PRNewswire/ -- As ASCRS and ASOA 2026 convene this week in Washington, D.C., the Saffron Solution is shifting the conversation in ophthalmology from incremental tools to a more urgent reality: most practices are not...
AppLovin Announces Succession Plans for Key Leadership Roles and New Independent Chairperson
AppLovin Announces Succession Plans for Key Leadership Roles and New Independent Chairperson
Apr 7, 2026
PALO ALTO, Calif.--(BUSINESS WIRE)-- AppLovin Corporation ( APP ) (“AppLovin” or the “Company”), the leading marketing platform, today announced succession plans relating to its executive management team and the appointment of Craig Billings as independent Chairperson of its Board of Directors (the “Board”). The Company announced the following management succession plans: Chief Technology Officer: Basil Shikin, AppLovin’s current Chief Technology...
Copyright 2023-2026 - www.financetom.com All Rights Reserved